Yumi Yashiro–Ohtani

Carisma Therapeutics (United States) — United States

Immunology and Microbiology · Life Sciences

23h-index5.2kcitations49works22.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(12), melanin and skin pigmentation(12), Developmental Biology and Gene Regulation(10), Immune Cell Function and Interaction(8), Cancer-related gene regulation(8)

Publications49 total

Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models
Nature Communications·2025· 4 citedOpen Access
Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models
Nature Communications·2025· 62 citedOpen Access
Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models
immuneACCESS·2024· 2 cited
Supplementary Figure 2 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Figure Legends 1-2 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Figure 1 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Figure Legends 1-2 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Figure 2 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Table 1 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Data from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Methods and Materials from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Data from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Table 1 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Figure 1 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Methods and Materials from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Human chimeric antigen receptor macrophages for cancer immunotherapy
Nature Biotechnology·2020· 1.3k citedOpen Access
THE NOTCH:MYC SIGNALING AXIS IN T CELL DEVELOPMENT AND TRANSFORMATION
2017
Protein Tyrosine Phosphatase PRL2 Mediates Notch and Kit Signals in Early T Cell Progenitors
Stem Cells·2016· 17 citedOpen Access
Modular domains within a super enhancer determine drug resistance in T-cell acute lymphoblastic leukemia
Experimental Hematology·2016· 2 cited
Alternative Super-Enhancer States Determine MYC Sensitivity to Notch and Brd4 Inhibitors in T Lymphoblastic Leukemia/Lymphoma
Blood·2014· 1 cited
page 1 of 3Next →

Frequent Co-authors

Warren S. Pear(33), Meenhard Herlyn(14), Levi J. Beverly(14), Chelsea C. Pinnix(13), John Tayu Lee(13), Ronan McDaid(13), Klara Balint(13), Patricia Brafford(13), Benjamin Himes(13), Susan E. Zabierowski(13), Katherine L. Nathanson(13), Ana Bengston(13), Pamela M. Pollock(13), Ashani T. Weeraratna(13), Brian J. Nickoloff(13), Anthony J. Capobianco(13), Zhaojun Liu(11), Toshiyuki Hamaoka(8), Hiromi Fujiwara(8), Olga Shestova(7)